Wolverine Trading, LLC Akebia Therapeutics, Inc. Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$0.94 - $1.55 $45,214 - $74,555	48,100 New	48,100 $63,000
Q1 2024 May 15, 2024	SELL	$1.27 - $2.24 $7,366 - $12,992	-5,800 Reduced 14.36%	34,600 $63,000
Q4 2023 Feb 14, 2024	SELL	$0.8 - $1.28 $4,080 - $6,528	-5,100 Reduced 11.21%	40,400 $50,000
Q3 2023 Nov 15, 2023	BUY	$0.87 - $1.84 $11,745 - $24,840	13,500 Added 42.19%	45,500 $51,000
Q2 2023 Aug 23, 2023	SELL	$0.51 - $1.43 $3,978 - $11,154	-7,800 Reduced 19.6%	32,000 $29,000
Q1 2023 May 15, 2023	BUY	$0.56 - $1.15 $22,288 - $45,770	39,800 New	39,800 $22,000
Q3 2022 Nov 14, 2022	BUY	$0.3 - $0.46 $8,010 - $12,282	26,700 New	26,700 $8,000
Q1 2022 May 16, 2022	SELL	$0.72 - $2.93 $13,968 - $56,842	-19,400 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$2.26 - $3.34 $43,843 - $64,796	19,400 New	19,400 $44,000
Q3 2021 Nov 12, 2021	SELL	$2.35 - $3.88 $92,355 - $152,484	-39,300 Closed	0 $0
Q2 2021 Aug 06, 2021	SELL	$2.83 - $4.2 $20,942 - $31,080	-7,400 Reduced 15.85%	39,300 $152,000
Q1 2021 May 14, 2021	BUY	$2.92 - $5.06 $39,712 - $68,816	13,600 Added 41.09%	46,700 $145,000
Q4 2020 Feb 12, 2021	BUY	$2.22 - $3.78 $25,752 - $43,848	11,600 Added 53.95%	33,100 $99,000
Q3 2020 Nov 13, 2020	BUY	$2.39 - $13.08 $18,403 - $100,716	7,700 Added 55.8%	21,500 $51,000
Q1 2020 May 11, 2020	SELL	$4.1 - $10.24 $56,169 - $140,288	-13,700 Reduced 49.82%	13,800 $110,000
Q4 2019 Feb 12, 2020	SELL	$3.16 - $6.73 $7,268 - $15,479	-2,300 Reduced 7.72%	27,500 $181,000
Q3 2019 Nov 14, 2019	SELL	$3.55 - $5.4 $14,200 - $21,600	-4,000 Reduced 11.83%	29,800 $123,000
Q2 2019 Aug 20, 2019	BUY	$4.1 - $8.05 $11,479 - $22,540	2,800 Added 9.03%	33,800 $164,000
Q1 2019 May 15, 2019	SELL	$5.41 - $8.73 $20,017 - $32,301	-3,700 Reduced 10.66%	31,000 $254,000
Q4 2018 Feb 14, 2019	BUY	$5.39 - $9.15 $187,033 - $317,505	34,700 New	34,700 $187,000

Others Institutions Holding AKBA

# of Institutions

120

Shares Held

54.9M

Call Options Held

291K

Put Options Held

179K

Black Rock Inc. New York, NY

11.6M
Shares

$26.4 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.1M
Shares

$22.9 Million
0.0% of portfolio
Satter Management Co., L.P.

5.75M
Shares

$13 Million
13.23% of portfolio
Geode Capital Management, LLC Boston, MA

4.75M
Shares

$10.8 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.72M
Shares

$8.44 Million
0.01% of portfolio

View Full List

About Akebia Therapeutics, Inc.

Ticker AKBA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 183,848,992
Market Cap $417M
Description
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...

More about AKBA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account